Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AChR
    (1)
  • Beta Amyloid
    (1)
  • COX
    (1)
  • ERK
    (2)
  • JNK
    (1)
  • MMP
    (1)
  • NF-κB
    (2)
  • Nrf2
    (1)
  • p38 MAPK
    (2)
  • Others
    (5)
Filter
Search Result
Results for "

ali 1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    15
    TargetMol | Activity
  • Peptide Products
    2
    TargetMol | inventory
  • Inhibitory Antibodies
    1
    TargetMol | natural
  • Dye Reagents
    1
    TargetMol | composition
  • Natural Products
    5
    TargetMol | Activity
  • Recombinant Protein
    6
    TargetMol | inventory
Nrf2 activator-1
T397192230697-41-1
Nrf2 activator-1 is a potent activator of NF-E2-related factor 2 (Nrf2) and can be used to study COPD and other respiratory diseases, including asthma, acute lung injury (ALI), acute respiratory distress syndrome (ARDS), and pulmonary fibrosis.
  • $195
In Stock
Size
QTY
Peimisine
T5S010619773-24-1
1. Peimisine (Ebeiensine) can affect M-receptor, excit β-receptor, restrain the release of internal calcium, and promote to releaseing nitrogen monoxidum in order to relax tracheal smooth muscle and relieve asthma. 2. Peimisine can attenuate lung tissue injury( ALI), LDH and MDA amount in ALI mice in a dose dependent manner, it also lower the total protein, total white blood cells, lymphocyte and neutrophilic leukocyte in bronchoalveolar lavage fluid( BALF); suggests that peimisine can play a protective role against LPS-induced acute lung injury. 3. Peimisine has the protective effect on the experimental hepatic fibrosis formation, the possible mechanisms are associated with inhibiting fibrogenesis and fibrosis accumulation, and decreasing lipid peroxidation. 4. Peimisine can inhibit angiotensin I converting enzyme activity in a dose-dependent manner, displaying 5 % inhibitory concentration values of 526.5 microM, thus, it may have antihypertensive action.
  • $36
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Isofraxidin
T5S0045486-21-5
1. Isofraxidin (Phytodolor) protects leukemia cells from radiation-induced apoptosis via ROS mitochondria pathway in a p53-independent manner. 2. Isofraxidin has a protective effect against LPS-induced ALI, and the protective effect of Isofraxidin seems to result from the inhibition of COX-2 protein expression in the lung, which regulates the production of PGE2. 3. Isofraxidin possesses significant analgesic and anti-inflammatory activities that may be mediated through the regulation of pro-inflammatory cytokines, TNF-α and the phosphorylation of p38 and ERK1 2.
  • $40
In Stock
Size
QTY
TargetMol | Inhibitor Sale
HCH6-1
T83131435265-06-7
HCH6-1 is a competitive Formyl peptide receptor 1 (FPR1) antagonist.
  • $58
In Stock
Size
QTY
TargetMol | Inhibitor Sale
NIP-22c
T870072309384-85-6
NIP-22c, a novel inhibitor of coronavirus 3CL pro, exhibits antiviral activity [1]. The compound's EC50 values are 4.6 μM for Verona, 1.1 μM for Calu3, 0.1 μM for Caco2, and 0.6 μM for HBTEC-ALI.
  • Inquiry Price
10-14 weeks
Size
QTY
Daxdilimab
T767672245966-28-1
Daxdilimab, an anti-ILT7 monoclonal antibody, targets the ILT7 cell surface molecule exclusive to pDC dendritic cells. It shows potential for treating acute lung injury (ALI) in COVID-19 infected patients, as indicated in research [1] [2].
  • Inquiry Price
Size
QTY
PI3Kδ-IN-14
T79658
PI3Kδ-IN-14 (Compound (S)-29), a selective PI3Kδ inhibitor with an IC50 of 0.8 nM and a Kd of 84.8 nM, targets the ATP-binding site within the kinase domain of PI3Kδ, exhibiting anti-inflammatory properties by impeding the PI3K AKT pathway and alleviating acute lung injury (ALI) [1].
  • Inquiry Price
Size
QTY
NF-κB-IN-8
T747992924565-59-1
NF-κB-IN-8 is a competitive antagonist of LPS for MD-2 binding, and it impedes the expression of inflammatory factors by engaging MD-2. Additionally, it inhibits ALP activity and is usable in inflammation research, including acute lung injury (ALI) [1].
  • $1,520
6-8 weeks
Size
QTY
JNK2-IN-1
T78829
JNK2-IN-1 (Compound J27), a selective JNK2 inhibitor with a dissociation constant (Kd) of 79.2 µM, exhibits anti-inflammatory effects by attenuating TNF-α and IL-6 secretion via inhibition of the NF-κB/MAPK pathway. It effectively mitigates symptoms associated with LPS-induced acute lung injury (ALI) and sepsis [1].
  • Inquiry Price
Size
QTY
Anti-inflammatory agent 17
T613022763226-84-0
Anti-inflammatory agent 17 an orally active anti-inflammatory agent, demonstrates potent efficacy in inhibiting the release of IL-6 and TNF-α without causing cytotoxicity in in vitro experiments. Furthermore, in vivo studies confirm its anti-inflammatory activity. Given its attributes, Compound 17 holds promise for investigating Acute lung injury (ALI) [1].
  • $1,520
6-8 weeks
Size
QTY
Tetrahydrocoptisine
T4S20634312-32-7
1. Tetrahydrocoptisine (STYLOPINE) has effective effects in suppressing inflammation. 2. Tetrahydrocoptisine possesses a protective effect on LPS-induced ALI through inhibiting of NF-κB signaling pathways, which may involve the inhibition of pulmonary inflammatory process. 3. Tetrahydrocoptisine has gastroprotective activity, is attributed to reducing NO production and adjusting the pro-inflammatory cytokine, inhibited neutrophil accumulation and NF-κB expression. 4. Tetrahydrocoptisine is an active anti-inflammatory constituent by inhibition of TNF-α, IL-6 and NO production possibly via down-regulation of NF-κB activation, phospho-ERK1/2 and phospho-p38MAPK signal pathways.
  • $44
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TABERSONINE HYDROCHLORIDE
T581029479-00-3
TABERSONINE HYDROCHLORIDE is a natural product extracted from the bean of Voacanga africana, is a potent inhibitor against Aβ(1 42) aggregation and toxicity.
  • $37
In Stock
Size
QTY
TargetMol | Inhibitor Sale
SZM-1209
T733822919801-86-6
SZM-1209 is a potent and specific RIPK1 inhibitor with oral activity, displaying a dissociation constant (Kd) of 85 nM. It demonstrates substantial anti-necroptotic efficacy with an EC50 of 22.4 ± 8.1 nM and possesses therapeutic effects against systemic inflammatory response syndrome (SIRS) and acute lung injury (ALI) [1].
  • $193
35 days
Size
QTY
Cyclosporin H
T2149383602-39-5
Cyclosporin H (CsH), a specific inhibitor of FPR1, inhibited lung inflammation in the ALI models. CsH significantly attenuated MTDs or NFP-induced inflammatory lung injury and activation of MAPK and AKT pathways. Cyclosporin H is a viral transduction enha
  • $125
In Stock
Size
QTY
Tabersonine
T32464429-63-4
Tabersonine (Tabersonin)is a terpene indole alkaloid found in the medicinal plant Catharanthus roseus.
  • $36
In Stock
Size
QTY
TargetMol | Inhibitor Sale